Crossmark Global Holdings, Inc. Bio Xcel Therapeutics, Inc. Transaction History

Crossmark Global Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$2.32 - $5.51 $64 - $154	-28 Reduced 0.22%	12,776 $38,000
Q3 2023 Nov 08, 2023	BUY	$2.49 - $11.85 $423 - $2,014	170 Added 1.35%	12,804 $43,000
Q2 2023 Jul 31, 2023	BUY	$6.39 - $28.58 $153 - $685	24 Added 0.19%	12,634 $121,000
Q1 2023 May 12, 2023	BUY	$17.7 - $33.24 $318 - $598	18 Added 0.14%	12,610 $235,000
Q4 2022 Jan 19, 2023	BUY	$10.25 - $22.43 $1,322 - $2,893	129 Added 1.04%	12,592 $270,000
Q3 2022 Nov 01, 2022	BUY	$11.19 - $17.89 $4,252 - $6,798	380 Added 3.14%	12,463 $147,000
Q2 2022 Jul 29, 2022	BUY	$9.03 - $21.55 $109,109 - $260,388	12,083 New	12,083 $159,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.